XML 55 R34.htm IDEA: XBRL DOCUMENT v3.22.4

Commitments and Contingencies (Tables)

12 Months Ended

Dec. 31, 2022

Commitments and Contingencies Disclosure [Abstract]

Summary of Outstanding Non-cancelable Purchase Obligations

As of December 31, 2022, the Company had the following outstanding non-cancelable purchase obligations (in thousands):

		Purchase Obligations Due In The Year Ending December 31,
		2023				2024				Total
Manufacture and supply of pamrevlumab		$	85			$	22,310			$	22,395
Manufacture and supply of roxadustat			6,126				2,369				8,495
Other purchases and programs			21,698				1,167				22,865
Total		$	27,909			$	25,846			$	53,755

X

- References

No definition available.

+ Details

Name:	us-gaap_CommitmentsAndContingenciesDisclosureAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of unconditional purchase obligation recognized as liability.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section 50
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 440
-SubTopic 10
-Section 50
-Paragraph 6
-URI https://asc.fasb.org/extlink&oid=123406679&loc=d3e25383-109308

+ Details

Name:	us-gaap_RecordedUnconditionalPurchaseObligationsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration